GlaxoSmithKline PLC (NYSE:GSK)

During the Trading Day
46.73 -0.87 / -1.83%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
46.73 0.00 / 0.00%
Volume: 10.7K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line8.8B7.6B8.8B4.7B
Total Other Cash Flow-2.7B-4.8B-1.1B-1.6B
Funds From Operations8.4B5.0B9.9B6.4B
Funds From/For Other Operating Expenses-660.1M-799.6M-346.1M-1.1B
Net Cash Flow - Operating Activities9.0B5.8B10.3B7.5B
InvestingIncrease In Investments-178.7M-522.4M-220.8M-151.5M
Decrease In Investments1.8B401.4M787.8M340.8M
Capital Expenditures-1.5B-1.7B-1.9B-2.0B
Fixed Asset Disposal161.0M108.3M3.0B434.7M
Net Assets From Acquisitions -425.0M-3.6B-386.8M-171.2M
Other Investing - Sources381.6M1.7B213.0M543.3M
Net Cash Flow Investing-376.7M-4.3B700.1M-1.9B
FinancingShort Term Borrowings59.6M-1.3B-2.9B-2.9B
Long Term Borrowings0.007.1B3.0B3.2B
Long Term Debt Reduction-61.2M-55.7M-48.6M--
Net Proceeds Stock Sale474.9M659.4M916.2M275.0M
Common Preferred Redeemed-3.6B-4.0B-2.4B-548.3M
Common Dividends-5.5B-6.1B-5.8B-6.3B
Cash Dividends Paid - Total-5.5B-6.1B-5.8B-6.3B
Other Sources - Financing177.1M0.000.000.00
Other Uses - Financing376.7M352.0M1.4B1.5B
Net Cash Flow - Financing-8.8B-4.1B-8.7B-7.7B
Exchange RateEffect of Exchange Rate on Cash-173.9M-146.5M-231.8M138.3M
Net Change In Cash-151.3M-2.6B2.3B-2.1B

To view my watchlist

Not a member yet?

Sign up now for a free account